FUJIFILM Advances Breast Imaging Technology with Aspire Cristalle at RSNA 2014
STAMFORD, Conn., Nov. 24, 2014 /PRNewswire/ -- (Booth # 2511, South Building) – FUJIFILM Medical Systems U.S.A., Inc., a global leader in technology innovation with the largest worldwide install base of digital mammography systems, will showcase the Aspire Cristalle at the 100th annual meeting of the Radiological Society of North America (RSNA) in Chicago, Ill.
"Aspire Cristalle nicely represents our latest culmination of imaging innovation and attention to every detail in design," said Rob Fabrizio, director of marketing and product development, Digital x-ray and Women's Health, FUJIFILM Medical Systems U.S.A., Inc. "The Aspire Cristalle will deliver brilliant images with gentle dose, while redefining the patient experience through a notably more comfortable exam."
New advancements include:
- Patient Experience enhancements such as our patented Comfort Paddles, are designed to make the most uncomfortable part of mammograms, more comfortable. The paddle's unique soft edges, flexible composition and 4-way pivot contours to the individual shape of the breast to more comfortably apply just the right compression for optimal tissue separation.
- Hexagonal Close Pattern (HCP) is an innovative detector pixel design, engineered to deliver higher acquisition efficiency for finer detail, higher DQE and lower dose than conventional square pixel arrays.
- The system's image quality is further enhanced with Fujifilm's renowned image processing— iAEC (intelligent automatic exposure control) coupled with ISC (image based spectrum conversion). Together these analyze the breast for glandular tissue characteristics, detect implants to optimize dose and processing, and precisely tune contrast to intelligently adapt for every breast type and to image implants with ease.
Fujifilm is dedicated to promoting the early detection of breast cancer through advances in digital mammography as well as supplementary screening or diagnostic testing, including breast ultrasound. Fujifilm continues to conduct research and collaborate with specialists in the field to develop revolutionary and reliable imaging technologies. Over 9,000 worldwide facilities trust Fujifilm's full field digital mammography solutions, making Fujifilm the most popular digital mammography system provider in the world.
"Fujifilm is constantly innovating to develop the most advanced digital mammography systems, to assist in the early detection of breast cancer," said Timothy M. Gustafson, RT (R), director of Imaging Service at White Memorial Medical Center in Los Angeles, California. "Aspire Cristalle brings together Fujifilm's extensive research, expertise and experience. The technology allows us to continue our mission – providing comprehensive cancer care for our community, combining sophisticated technology with a warm, caring touch."
To register for a product demonstration at RSNA, please click here. For more information, please visit: http://digital-mammography.fujimed.com/.
About Fujifilm
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women's health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. supplies high quality, technologically advanced FUJINON brand endoscopes to the medical market. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visit www.fujimed.com and www.fujifilmendoscopy.com.
FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation and leading-edge products to a broad spectrum of industries, including: healthcare, with medical systems, pharmaceuticals and cosmetics; graphic systems; highly functional materials, such as flat panel display materials; optical devices, such as broadcast and cinema lenses; digital imaging; and document products. These are based on a vast portfolio of chemical, mechanical, optical, electronic, software and production technologies. In the year ended March 31, 2014, the company had global revenues of $23.9 billion, at an exchange rate of 102 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
All product and company names herein may be trademarks of their registered owners.
Photo - http://photos.prnewswire.com/prnh/20141124/160612
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/fujifilm-advances-breast-imaging-technology-with-aspire-cristalle-at-rsna-2014-300000459.html
SOURCE FUJIFILM Medical Systems U.S.A., Inc.
Share this article